| |||
 | |||
 |
Vitamin A (Retinol) | ||
|
Vitamin D | ||
| |||
| Pronunciation |
 (MAG
al
drate) |
 |
| U.S. Brand Names |
| Riopan®[OTC] |
|
| Generic Available |
|
Yes |
|
| Synonyms |
| Hydromagnesium Aluminate |
|
| Pharmacological Index |
|
Antacid |
|
| Use |
|
Symptomatic relief of hyperacidity associated with peptic ulcer, gastritis, peptic esophagitis and hiatal hernia |
|
| Pregnancy Risk Factor |
|
C |
|
| Contraindications |
|
Patients with colostomy or an ileostomy; appendicitis; ulcerative colitis; diverticulitis |
|
| Adverse Reactions |
|
>10%: Gastrointestinal: Constipation, chalky taste, stomach cramps, fecal impaction 1% to 10%: Gastrointestinal: Nausea, vomiting, discoloration of feces (white speckles) |
|
| Drug Interactions |
|
Tetracyclines, digoxin, indomethacin, iron salts, isoniazid |
|
| Usual Dosage |
|
Adults: Oral: 540-1080 mg between meals and at bedtime |
|
| Dietary Considerations |
|
Should be administered on empty stomach |
|
| Mental Health: Effects on Mental Status |
|
None reported |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
Chew tablets thoroughly before swallowing with water; notify physician if relief is not obtained or if signs of bleeding from GI tract occur |
|
| Nursing Implications |
|
Administer 1-2 hours apart from oral drugs; shake suspensions well Monitor for constipation, fecal impaction, diarrhea, and hypophosphatemia |
|
| Dosage Forms |
|
Suspension, oral: 540 mg/5 mL (360 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
